Deep Track Capital, LP
Q4 2023 13F-HR Holdings
Net value change ($000)
+403,525
(15.6%)
New positions
13
Sold out positions
18
Turnover %
26.5%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ARGX | 114,129 | NEW |
| SpringWorks Therapeutics, Inc. | 66,330 | 80.9% |
| Ambrx Biopharma, Inc. | 52,836 | NEW |
| SRPT | 48,215 | NEW |
| TRML | 47,539 | NEW |
| ABVX | 45,983 | NEW |
| SYRE | 42,023 | NEW |
| AUTL | 41,488 | 118.7% |
| OCUL | 41,169 | NEW |
| ACLX | 40,246 | NEW |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
139,741
(4.7% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|